
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health is currently facing challenges in capturing leverage in its operating costs, but with planned cost management initiatives and optimization of procurement activities, the company is still expected to achieve its 2026 financial guidance. The company's 2026 gross margin percentage is likely to experience a slight lift due to its faster revenue growth in acute therapy. Despite potential risks in the specialty pharmacy space, the extreme share price weakness offers an excellent buying opportunity for investors with a long-term horizon as the company is well-positioned to compete and is expected to see top-line growth and margin improvement in the coming years.
Bears say
Option Care Health is facing a challenging future due to a significant decline in patient census, lower expected revenue and adjusted EPS, and a shift to lower-margin therapies. While the company has a strong position in the specialty market, it is at risk of being overshadowed by competitors and biosimilar/generic launches. The current stock price may be an opportunity for investors, but there are downside risks such as slowing growth and increased competition, which could limit potential upside. Ultimately, the stock may be fairly valued at this time with the company's targets already reflected in consensus estimates.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares